The rise of Viagra initially fueled a period of growth for the drug industry, however recent developments present a complicated outlook for shareholders. Generic alternatives are eroding revenue, and continued patent https://inesdbve606788.fireblogz.com/72722177/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-play